Ocular Therapeutix (OCUL) Misses Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: OCUL) | Delayed: 7.10 +0.28 (4.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.82 | 52 Week High | $14.50 | |||
| Open | $7.09 | 52 Week Low | $4.04 | |||
| Day High | $7.16 | P/E | N/A | |||
| Day Low | $6.83 | EPS | $0.00 | |||
| Volume | 1,813,163 | |||||
